StockData
Matinas BioPharma Holdings, Inc. logo

Matinas BioPharma Holdings, Inc. (MTNB) KPIs and segments

MTNBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.91+0.05 (+6.35%)

Close on Nov 18, 2026Market cap $13.37MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Matinas BioPharma's business

Coming soon

This tab will track the numbers specific to Matinas BioPharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?